Atkin-Flaitz syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1193OMIM:300431Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Atkin-Flaitz syndrome, also known as X-linked mental retardation Atkin type, is a very rare genetic condition that primarily affects males. It was first described by Atkin and Flaitz and is characterized by intellectual disability, distinctive facial features, and short stature. Affected individuals typically show moderate to severe intellectual disability, which becomes apparent in early childhood as developmental milestones are delayed. The facial features associated with this syndrome may include a broad face, a prominent forehead, a short nose with a broad tip, and a wide mouth. Some individuals may also have a large head (macrocephaly) and obesity or a tendency toward being overweight. Because this condition is X-linked, it mainly affects boys and men, while females who carry the gene change are usually unaffected or only mildly affected. There is currently no cure for Atkin-Flaitz syndrome. Treatment focuses on managing symptoms and supporting development through early intervention programs, special education, speech therapy, and occupational therapy. Regular follow-up with a team of specialists helps ensure the best possible quality of life for affected individuals.

Also known as:

Key symptoms:

Intellectual disabilityDelayed speech and language developmentShort statureBroad or round faceProminent foreheadShort nose with broad tipWide mouthLarge head size (macrocephaly)Obesity or tendency to be overweightDelayed motor milestonesBehavioral difficultiesLow muscle tone in infancy

Clinical phenotype terms (16)— hover any for plain English
Maxillary lateral incisor microdontiaHP:0001593
Inheritance

X-linked recessive

Carried on the X chromosome; typically affects males more than females

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Atkin-Flaitz syndrome.

View clinical trials →

No actively recruiting trials found for Atkin-Flaitz syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Atkin-Flaitz syndrome community →

No specialists are currently listed for Atkin-Flaitz syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Atkin-Flaitz syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Atkin-Flaitz syndromeForum →

No community posts yet. Be the first to share your experience with Atkin-Flaitz syndrome.

Start the conversation →

Latest news about Atkin-Flaitz syndrome

No recent news articles for Atkin-Flaitz syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What level of intellectual disability does my child have, and what support services are recommended?,Should we pursue genetic testing to confirm the diagnosis or identify the specific gene involved?,What early intervention therapies should we start, and how often?,Are there any medical complications we should watch for as my child grows?,What educational accommodations should we request at school?,Is there a risk that future children could also be affected, and should we see a genetic counselor?,Are there any clinical trials or research studies we could participate in?

Common questions about Atkin-Flaitz syndrome

What is Atkin-Flaitz syndrome?

Atkin-Flaitz syndrome, also known as X-linked mental retardation Atkin type, is a very rare genetic condition that primarily affects males. It was first described by Atkin and Flaitz and is characterized by intellectual disability, distinctive facial features, and short stature. Affected individuals typically show moderate to severe intellectual disability, which becomes apparent in early childhood as developmental milestones are delayed. The facial features associated with this syndrome may include a broad face, a prominent forehead, a short nose with a broad tip, and a wide mouth. Some indiv

How is Atkin-Flaitz syndrome inherited?

Atkin-Flaitz syndrome follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Atkin-Flaitz syndrome typically begin?

Typical onset of Atkin-Flaitz syndrome is childhood. Age of onset can vary across affected individuals.